Smoking cessation, version 3.2022, NCCN clinical practice guidelines in oncology
Although the harmful effects of smoking after a cancer diagnosis have been clearly
demonstrated, many patients continue to smoke cigarettes during treatment and beyond …
demonstrated, many patients continue to smoke cigarettes during treatment and beyond …
Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling
P Zhu, Z Jin, G Kang, Y Jia, D Liu, Q Zhang… - Cell Communication and …, 2022 - Springer
Background Immunotherapy has proven to be an emerging treatment for non-small-cell lung
cancer in recent years. Notably, smokers show higher programmed cell death ligand-1 (PD …
cancer in recent years. Notably, smokers show higher programmed cell death ligand-1 (PD …
Tobacco exposure and immunotherapy response in PD-L1 positive lung cancer patients
Background Tobacco exposure contributes to over 80% of lung cancer cases. Smoking is
associated with programmed death-ligand 1 (PD-L1) tumor expression and better outcomes …
associated with programmed death-ligand 1 (PD-L1) tumor expression and better outcomes …
Tobacco and E-cigarette use among cancer survivors in the United States
Background Limited information exist on tobacco and e-cigarette use patterns in cancer
survivors. The purpose of this study is to report on use patterns in cancer survivors …
survivors. The purpose of this study is to report on use patterns in cancer survivors …
A systematic review and meta-analysis of e-cigarette use among cancer survivors
MA Lopez-Olivo, J James, J James, KJ Krause… - Journal of Cancer …, 2024 - Springer
Purpose We conducted a systematic review and meta-analysis to determine the use of e-
cigarettes among cancer survivors, factors associated with their use, and prevalence of e …
cigarettes among cancer survivors, factors associated with their use, and prevalence of e …
[HTML][HTML] Peer Reviewed: Use of Cigarettes and E-Cigarettes and Dual Use Among Adult Employees in the US Workplace
Methods We used data from the 2017 Behavioral Risk Factor Surveillance System to
examine the prevalence of cigarette use, e-cigarette use, dual use, and quit attempts. We …
examine the prevalence of cigarette use, e-cigarette use, dual use, and quit attempts. We …
Examining the accuracy of self-reported smoking-related exposure among recently diagnosed nonmuscle invasive bladder cancer patients
S Petruzella, BH Bochner, J Kenney… - The Journal of …, 2021 - auajournals.org
Purpose: Cigarette smoking is a risk factor for developing nonmuscle invasive bladder
cancer, and continued smoking exposure after diagnosis may increase the likelihood of …
cancer, and continued smoking exposure after diagnosis may increase the likelihood of …
[PDF][PDF] 从微观到宏观漫谈肿瘤免疫检查点抑制剂疗效的影响因素
杜成， 金山琇， 谢晓冬 - 中国癌症防治杂志, 2022 - zgazfz.com
免疫检查点抑制剂是免疫治疗的新方式, 是通过改变肿瘤免疫微环境而达到免疫细胞对肿瘤细胞
进行消灭的目的. 2018 年免疫检查点抑制剂疗法获得诺贝尔奖后, 免疫检查点抑制剂治疗成为 …
进行消灭的目的. 2018 年免疫检查点抑制剂疗法获得诺贝尔奖后, 免疫检查点抑制剂治疗成为 …
Understanding changes in substance use in the adolescent and young adult cancer population: a literature review
G Kenny, J Cargill, R Dommett, D Bassi… - Cancer Nursing …, 2025 - journals.rcni.com
The nature of the risks involved in adolescents and young adults' substance use has
evolved considerably in the 21st century. While there has been a decline in the use of some …
evolved considerably in the 21st century. While there has been a decline in the use of some …